CapitaLand Opens $1.09 Billion Geneo Hub to Power Singapore's Biotech Future

CapitaLand Group has officially launched Geneo, a major life sciences and innovation hub located in Singapore Science Park.

The project involves investments totaling around S$1.4 billion or about $1.09 billion.

Rejuvenating Singapore's Historic Research Park

Geneo forms part of a broader effort to refresh the nation's first research and development park with modern facilities.

It covers three buildings with a combined gross floor area of roughly 180,600 square meters.

About 80,000 square meters are dedicated to specialized biomedical research labs and flexible workspaces.

Key tenants already include leading organizations such as A*STAR and several international firms in biotech and advanced manufacturing.

The hub features Singapore's largest coworking laboratory space, which helps smaller teams access high-end equipment.

All properties hold the top Green Mark Platinum rating, underscoring a focus on energy-efficient design.

This development supports Singapore's push to become a global leader in life sciences by linking research directly to commercial outcomes.

For everyday residents it could translate into new local jobs and faster progress toward better medicines and health solutions.

Looking forward the integrated model of labs and collaborative areas is likely to speed up innovation cycles across the sector.

Overall Geneo positions the city-state to attract more global talent and investment in cutting-edge science.